Free Initial Consultation
Local:
636-530-9199
Toll Free:
866-585-4570
defective drug attorneys st louis

Promotion of wider use of drug may not be wise

Medications are designed and developed to treat illnesses or symptoms or, in some cases, to prevent other problems from occurring. It is reasonable for the public to wish to trust in the reliability and safety of all drugs. However, all drugs have some type of side effects and those need to be monitored to ensure that a cure for one thing does not result in yet a new problem or illness.

The Federal Drug Administration (FDA) works hard to ensure safety in all drugs and the medical community and companies producing pharmaceuticals and medications have some ability to monitor medications and drug interactions and side effects as well. One class of drug is currently being touted for its abilityt o reduce cholsterol and inflammation with some medical professionals encouring more widespread use. Statins are a type of medication that is the subject of this discussion.

Medications are designed and developed to treat illnesses or symptoms or, in some cases, to prevent other problems from occurring. It is reasonable for the public to wish to trust in the reliability and safety of all drugs. However, all drugs have some type of side effects and those need to be monitored to ensure that a cure for one thing does not result in yet a new problem or illness.

The Federal Drug Administration (FDA) works hard to ensure safety in all drugs and the medical community and companies producing pharmaceuticals and medications have some ability to monitor medications and drug interactions and side effects as well. One class of drug is currently being touted for its abilityt o reduce cholsterol and inflammation with some medical professionals encouring more widespread use. Statins are a type of medication that is the subject of this discussion.

Source: TIME, “Statins have few side effects, but should more people be taking them?,” Alice Park, July 10, 2013

Tags:

Privacy Policy | Business Development Solutions by FindLaw, a Thomson Reuters business.